儿童癌症幸存者的表观遗传衰老
Prerna Kumar1, Beth Speckhart2, Yanzhi Wang3
1Department of Pediatrics, University of Illinois College of Medicine Peoria.
Journal of pediatric hematology/oncology
|August 29, 2025
概括
儿童癌症幸存者因表观遗传变化而呈现加快的衰老. 放射治疗进一步增加了表观遗传年龄,
科学领域:
- 癌症学
- 遗传学
- 老龄化研究
背景情况:
- 儿童癌症幸存者往往会出现长期健康问题,包括加速衰老的迹象.
- 这种晚年衰老的潜在机制尚未完全理解,但怀疑存在表观遗传变化.
- 正在研究表观遗传调节,特别是DNA甲基化,作为潜在的贡献者.
研究的目的:
- 调查儿童癌症幸存者与他们的健康兄弟姐妹之间的表观遗传年龄差异.
- 探索癌症前期治疗,特别是放射治疗与幸存者的表观遗传年龄之间的关联.
主要方法:
- 一项截面研究比较了20名儿童癌症幸存者 (治疗后≥5年) 和20名健康的兄弟姐妹.
- 从外围血液样本分析了DNA甲基化模式,以计算表观遗传年龄.
- 统计分析包括配对的t测试或威尔科克森签名等级测试.
主要成果:
- 与健康的兄弟姐妹相比,儿童癌症幸存者表现出显著更高的表观遗传年龄 (平均差异为1. 41年,P=0. 016).
- 与兄弟姐妹相比,接受放射治疗的幸存者表现出更明显的表观遗传年龄增加 (平均差异为2. 55年,P=0. 012).
结论:
- 儿童癌症的幸存者与健康的兄弟姐妹相比, 表观遗传衰老加速.
- 癌症治疗期间的辐射暴露与表观遗传年龄的增加有关.
- 在儿童癌症幸存者中观察到的加速衰老可能是DNA甲基化驱动的表观遗传调节.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Genomic Imprinting and Inheritance
35.2K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.2K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K


